Bio Techne Corp Stock Market Value
| TECH Stock | USD 63.17 1.63 2.52% |
| Symbol | Bio |
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Dividend Share 0.32 | Earnings Share 0.52 | Revenue Per Share | Quarterly Revenue Growth (0) |
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Bio Techne 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Techne's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Techne.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Bio Techne on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Techne Corp or generate 0.0% return on investment in Bio Techne over 90 days. Bio Techne is related to or competes with Moderna, Exelixis, Biomarin Pharmaceutical, Madrigal Pharmaceuticals, Avidity Biosciences, Caris Life, and Jazz Pharmaceuticals. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instrum... More
Bio Techne Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Techne's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Techne Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.87 | |||
| Information Ratio | 0.0232 | |||
| Maximum Drawdown | 10.34 | |||
| Value At Risk | (2.93) | |||
| Potential Upside | 3.76 |
Bio Techne Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Techne's standard deviation. In reality, there are many statistical measures that can use Bio Techne historical prices to predict the future Bio Techne's volatility.| Risk Adjusted Performance | 0.058 | |||
| Jensen Alpha | 0.0178 | |||
| Total Risk Alpha | (0.1) | |||
| Sortino Ratio | 0.028 | |||
| Treynor Ratio | 0.0952 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.058 | |||
| Market Risk Adjusted Performance | 0.1052 | |||
| Mean Deviation | 1.78 | |||
| Semi Deviation | 1.73 | |||
| Downside Deviation | 1.87 | |||
| Coefficient Of Variation | 1552.74 | |||
| Standard Deviation | 2.25 | |||
| Variance | 5.06 | |||
| Information Ratio | 0.0232 | |||
| Jensen Alpha | 0.0178 | |||
| Total Risk Alpha | (0.1) | |||
| Sortino Ratio | 0.028 | |||
| Treynor Ratio | 0.0952 | |||
| Maximum Drawdown | 10.34 | |||
| Value At Risk | (2.93) | |||
| Potential Upside | 3.76 | |||
| Downside Variance | 3.49 | |||
| Semi Variance | 2.98 | |||
| Expected Short fall | (2.09) | |||
| Skewness | 0.5784 | |||
| Kurtosis | 0.0638 |
Bio Techne Corp Backtested Returns
Bio Techne is very steady at the moment. Bio Techne Corp secures Sharpe Ratio (or Efficiency) of 0.06, which signifies that the company had a 0.06 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Bio Techne Corp, which you can use to evaluate the volatility of the firm. Please confirm Bio Techne's Mean Deviation of 1.78, risk adjusted performance of 0.058, and Downside Deviation of 1.87 to double-check if the risk estimate we provide is consistent with the expected return of 0.13%. Bio Techne has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.42, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Techne will likely underperform. Bio Techne Corp right now shows a risk of 2.24%. Please confirm Bio Techne Corp treynor ratio, expected short fall, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Bio Techne Corp will be following its price patterns.
Auto-correlation | 0.40 |
Average predictability
Bio Techne Corp has average predictability. Overlapping area represents the amount of predictability between Bio Techne time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Techne Corp price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Bio Techne price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 10.21 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Bio Techne Correlation, Bio Techne Volatility and Bio Techne Performance module to complement your research on Bio Techne. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Bio Techne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.